Brooke N Meader1, Alessandro Albano1, Hilal Sekizkardes1, Angela Delaney1,2. 1. Eunice Kennedy Shriver National Institute of Child Health and Human Development, NIH, Bethesda, Maryland. 2. Division of Endocrinology, St. Jude Children's Research Hospital, Memphis, Tennessee.
Abstract
CONTEXT: Loss-of-function mutations in the imprinted genes MKRN3 and DLK1 cause central precocious puberty (CPP) but whole gene deletions have not been reported. Larger deletions of the chromosome 15q11-13 imprinted locus, including MKRN3, cause Prader-Willi syndrome (PWS). CPP has been reported in PWS but is not common, and the role of MKRN3 in PWS has not been fully elucidated. OBJECTIVE: To identify copy number variants in puberty-related, imprinted genes to determine their role in CPP. METHODS: Probands with idiopathic CPP had chromosomal microarray (CMA) and targeted deletion/duplication testing for MKRN3 and DLK1. RESULTS: Sixteen female probands without MKRN3 or DLK1 variants identified by Sanger sequencing were studied. Whole gene deletions of MKRN3 were identified in 2 subjects (13%): a complete deletion of MKRN3 in Patient A (pubertal onset at 7 years) and a larger deletion involving MAGEL2, MKRN3, and NDN in Patient B (pubertal onset 5.5 years). Both were paternally inherited. Patient B had no typical features of PWS, other than obesity, which was also present in her unaffected family. CONCLUSIONS: We identified 2 cases of whole gene deletions of MKRN3 causing isolated CPP without PWS. This is the first report of complete deletions of MKRN3 in patients with CPP, emphasizing the importance of including copy number variant analysis for MKRN3 mutation testing when a genetic diagnosis is suspected. We speculate that there is a critical region of the PWS locus beyond MKRN3, MAGEL2, and NDN that is responsible for the PWS phenotype. Published by Oxford University Press on behalf of the Endocrine Society 2020.
CONTEXT: Loss-of-function mutations in the imprinted genes MKRN3 and DLK1 cause central precocious puberty (CPP) but whole gene deletions have not been reported. Larger deletions of the chromosome 15q11-13 imprinted locus, including MKRN3, cause Prader-Willi syndrome (PWS). CPP has been reported in PWS but is not common, and the role of MKRN3 in PWS has not been fully elucidated. OBJECTIVE: To identify copy number variants in puberty-related, imprinted genes to determine their role in CPP. METHODS: Probands with idiopathic CPP had chromosomal microarray (CMA) and targeted deletion/duplication testing for MKRN3 and DLK1. RESULTS: Sixteen female probands without MKRN3 or DLK1 variants identified by Sanger sequencing were studied. Whole gene deletions of MKRN3 were identified in 2 subjects (13%): a complete deletion of MKRN3 in Patient A (pubertal onset at 7 years) and a larger deletion involving MAGEL2, MKRN3, and NDN in Patient B (pubertal onset 5.5 years). Both were paternally inherited. Patient B had no typical features of PWS, other than obesity, which was also present in her unaffected family. CONCLUSIONS: We identified 2 cases of whole gene deletions of MKRN3 causing isolated CPP without PWS. This is the first report of complete deletions of MKRN3 in patients with CPP, emphasizing the importance of including copy number variant analysis for MKRN3 mutation testing when a genetic diagnosis is suspected. We speculate that there is a critical region of the PWS locus beyond MKRN3, MAGEL2, and NDN that is responsible for the PWS phenotype. Published by Oxford University Press on behalf of the Endocrine Society 2020.
Authors: Larissa G Gomes; Marina Cunha-Silva; Raiane P Crespo; Carolina O Ramos; Luciana R Montenegro; Ana Canton; Melissa Lees; Helen Spoudeas; Andrew Dauber; Delanie B Macedo; Danielle S Bessa; Gustavo A Maciel; Edmund C Baracat; Alexander A L Jorge; Berenice B Mendonca; Vinicius N Brito; Ana Claudia Latronico Journal: J Clin Endocrinol Metab Date: 2019-06-01 Impact factor: 5.958
Authors: Delanie B Macedo; Monica M França; Luciana R Montenegro; Marina Cunha-Silva; Danielle S Best; Ana Paula Abreu; Ursula B Kaiser; Berenice B Mendonca; Alexander A L Jorge; Vinicius N Brito; Ana Claudia Latronico Journal: Neuroendocrinology Date: 2018-05-15 Impact factor: 4.914
Authors: Ana Paula Abreu; Andrew Dauber; Delanie B Macedo; Sekoni D Noel; Vinicius N Brito; John C Gill; Priscilla Cukier; Iain R Thompson; Victor M Navarro; Priscila C Gagliardi; Tânia Rodrigues; Cristiane Kochi; Carlos Alberto Longui; Dominique Beckers; Francis de Zegher; Luciana R Montenegro; Berenice B Mendonca; Rona S Carroll; Joel N Hirschhorn; Ana Claudia Latronico; Ursula B Kaiser Journal: N Engl J Med Date: 2013-06-05 Impact factor: 91.245
Authors: Danielle S Bessa; Delanie B Macedo; Vinicius N Brito; Monica M França; Luciana R Montenegro; Marina Cunha-Silva; Leticia G Silveira; Tiago Hummel; Ignacio Bergadá; Debora Braslavsky; Ana Paula Abreu; Andrew Dauber; Berenice B Mendonca; Ursula B Kaiser; Ana Claudia Latronico Journal: Neuroendocrinology Date: 2016-05-26 Impact factor: 4.914
Authors: Deniz Kanber; Jacques Giltay; Dagmar Wieczorek; Corinna Zogel; Ron Hochstenbach; Almuth Caliebe; Alma Kuechler; Bernhard Horsthemke; Karin Buiting Journal: Eur J Hum Genet Date: 2008-12-10 Impact factor: 4.246
Authors: Delanie B Macedo; Ana Paula Abreu; Ana Claudia S Reis; Luciana R Montenegro; Andrew Dauber; Daiane Beneduzzi; Priscilla Cukier; Leticia F G Silveira; Milena G Teles; Rona S Carroll; Gil Guerra Junior; Guilherme Guaragna Filho; Zoran Gucev; Ivo J P Arnhold; Margaret de Castro; Ayrton C Moreira; Carlos Eduardo Martinelli; Joel N Hirschhorn; Berenice B Mendonca; Vinicius N Brito; Sonir R Antonini; Ursula B Kaiser; Ana Claudia Latronico Journal: J Clin Endocrinol Metab Date: 2014-03-14 Impact factor: 5.958